Login / Signup
Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
Varsha Bhat
Vivien A Sheehan
Published in:
Expert review of hematology (2024)
Implementing a multi-omics-based approach will facilitate the discovery of objective and validated biomarkers for acute pain.
Keyphrases
</>
sickle cell disease
liver failure
chronic pain
respiratory failure
pain management
neuropathic pain
drug induced
aortic dissection
small molecule
single cell
hepatitis b virus
high throughput
extracorporeal membrane oxygenation
quality improvement
spinal cord
intensive care unit
mechanical ventilation